The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study

AIMS: Acute coronary syndromes (ACSs) are driven by inflammation within coronary plaque. Interleukin-1 (IL-1) has an established role in atherogenesis and the vessel-response to injury. ACS patients have raised serum markers of inflammation. We hypothesized that if IL-1 is a driving influence of inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Morton, Allison C., Rothman, Alexander M. K., Greenwood, John P., Gunn, Julian, Chase, Alex, Clarke, Bernard, Hall, Alistair S., Fox, Keith, Foley, Claire, Banya, Winston, Wang, Duolao, Flather, Marcus D., Crossman, David C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320321/
https://www.ncbi.nlm.nih.gov/pubmed/25079365
http://dx.doi.org/10.1093/eurheartj/ehu272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320321/
https://www.ncbi.nlm.nih.gov/pubmed/25079365
http://dx.doi.org/10.1093/eurheartj/ehu272

Ejemplares similares